Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax

Total 46 results found. Search for [ ZyCoV-D ]

Results 1 to 21 of 46
Vivek Punj
New Delhi, October 27, 2020
Johnson & Johnson says first batches of COVID-19 vaccine may be available as soon as JanuaryAmid ongoing coronavirus pandemic, Johnson & Johnson has said that the first batches of its COVID-19 vaccine could be available as soon as in January. The first batches of its shots are expected to be available for emergency use by starting 2021, Ruxandra Draghia-Akli, the company's head of public health research and development, said in a presentation at the World Health Summit.Bharti Airtel...

PB Jayakumar & Joe C Mathew
October 26, 2020
Zydus Cadila's COVID-19 candidate vaccine ZyCov-D, which is currently undergoing second phase of clinical trials in India, is likely to enter Phase III final stage of clinical trials by December 2020

October 12, 2020
Coronavirus vaccine: There are four US-based companies whose vaccine candidates have moved into the crucial phase-3 development phase. This includes--Pfizer, Moderna, Johnson & Johnson, and Novavax

October 3, 2020
COVID-19 vaccine: A principal investigator from a trial site in Maharashtra said that they are expecting to finish enrolling the participants within the next two months after which they will be monitored for the vaccine's efficacy

October 2, 2020
Coronavirus cases in India: The active patients' tally in India stands at 9,42,217; around 53,52,078 patients have recovered and 99,773 have succumbed to the deadly virus so far

October 1, 2020
Coronavirus vaccine update: In India, there are three COVID-19 vaccines under human trials--Bharat Biotech's COVAXIN, Oxford's COVDSHIELD, and Zydus Cadila's ZyCoV-D. Serum Institute has already begun a phase-3 trial of Oxford vaccine candidates at 17 sites

September 30, 2020
COVID-19 vaccine being developed by AstraZeneca-Oxford University, Novavax, Moderna, Pfizer Inc and Johnson & Johnson are already in an advanced stage of testing

September 15, 2020
COVID-19 vaccine candidates being developed by Cadila Healthcare and Bharat Biotech have completed the phase one of the study while Pune-based Serum Institute of India (SII) will begin with Phase 3 clinical trial after getting regulatory nod, says ICMR chief

PB Jayakumar
September 9, 2020
Serum has also started manufacturing the vaccine, targeting to use in India and 92 other countries upon completion of trials and regulatory clearances

August 23, 2020
Initially, the ICMR vaccine portal will disseminate information on coronavirus vaccine in India. However, with time, data available for all the vaccines will be added to the portal

PB Jayakumar
August 22, 2020
Centre has sought 68 crore doses for 130 crore Indian citizens from Serum Institute by June, next year

August 21, 2020
Coronavirus vaccine update: Serum Institute of India that is manufacturing the Oxford University-AstraZeneca vaccine will conductt the trials wouldon 1,600 healthy volunteers with no history of COVID-19

August 19, 2020
Coronavirus vaccine news update: Oxford vaccine could be the first antidote to be released in India. Bharat Biotech's COVAXIN and Zydus Cadila's ZyCoV-D are in initial stages of trials

New Delhi, August 19, 2020
COVID-19 pandemic: WHO lambasts 'vaccine nationalism' in last-resort attempt against hoardingNations that hoard possible COVID-19 vaccines while excluding others will deepen the pandemic, World Health Organization (WHO) chief Tedros Adhanom Ghebreyesus said on Tuesday, issuing a last-ditch call for countries to join a global vaccine pact. The WHO has an Aug. 31 deadline for wealthier nations to join the \"COVAX Global Vaccines Facility\" for sharing vaccine hopefuls with developing countries...

August 18, 2020
Oxford vaccine news update: The government had formed a coronavirus vaccine expert committee that held discussions on the distribution plans of the vaccine. The trials would be conducted across 10 centres at first

Joe C Mathew
August 14, 2020
Coronavirus vaccine news update: India's own research institution, the Indian Council of Medical Research (ICMR) is on record for its push to cut down red tapism and accelerate the development of COVID-19 vaccines

PB Jayakumar
August 13, 2020
Remdesivir price: Zydus is the fifth Indian company to launch the drug for coronavirus treatment after Hetero Labs, Cipla, Mylan NV and Jubilant Life Sciences. Priced at Rs 2,800 for a 100 mg lyophilized injection, its brand 'Remdac' will be the most economical

August 7, 2020
Coronavirus vaccine news update: Serum Institute of India would have exclusive rights for the supply of the Novavax COVID-19 vaccine in India

Chitranjan Kumar
August 5, 2020
Share market updates and analysis for August 6: RBI policy announcement, earnings announcements and global cues to set tone for stock markets

PB Jayakumar
August 5, 2020
The vaccine, using the platform of plasmid DNA, was found to be safe and well tolerated in the Phase I, which began on 15 July, said Zydus Cadila

PAGES 1 OF 3  123